The TE Air is reportedly the first handheld ultrasound device to offer dual connectivity to mobile devices or touch-based ultrasound systems.
Offering the promise of enhanced connectivity and dedicated presets for a variety of clinical exams, Mindray has launched TE Air, a wireless handheld ultrasound modality.
Mindray said the TE Air offers enhanced utility and accessibility, claiming that the device is the first handheld ultrasound that can be connected to mobile devices or the touch-based TE X Ultrasound System.
“The TE Air is a leap forward in ultrasound technology, offering comprehensive functionality inside or outside the hospital environment,” noted Wayne Quinn, the president of Mindray North America. “The new 2-in-1 innovative solution empowers clinicians to overcome the traditional constraints of cords and confined spaces, giving them access to premium scanning capability when and where they need it.”
The company noted a number of additional features with TE Air including:
• a phased array with exam presets for a variety of clinical exams including cardiac exams, transcranial imaging, lung imaging and OB/GYN exams;
• single crystal technology that facilitates high-resolution imaging quality; and
• a waterproof design that allows for easy cleaning of the device with compatible disinfectant products.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.